The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 364.50
Bid: 363.50
Ask: 365.00
Change: 3.50 (0.97%)
Spread: 1.50 (0.413%)
Open: 362.00
High: 366.50
Low: 361.50
Prev. Close: 361.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Statement

25 Jan 2010 07:00

RNS Number : 0309G
Lupus Capital PLC
25 January 2010
 



PRE-CLOSE TRADING STATEMENT AND NOTICE OF RESULTS

Lupus Capital plc ("Lupus" or the "Group") announces a pre-close trading statement for the financial year ended 31 December 2009 and an update on current trading and the Group's financial position.

Lupus Capital plc, the security, residential products and marine breakaway couplings group, today issues the following trading update for the financial year ended 31 December 2009, in advance of its preliminary results announcement on Thursday 25 March 2010.  Numbers contained within this update are preliminary and remain subject to audit.

Total sales for the year are expected to be £241.6 million, a decrease of approximately nine per cent. compared with 2008 (£266.6 million). On a constant currency basis, this represents a fall in total sales of approximately 17 per cent. compared with 2008.  Results for the 12 months to 31 December are expected to be in line with, or marginally ahead of, the current consensus of analysts' 2009 expectations.  

Given that 2009 was a challenging year of transition and disruption for the Group, the Board is pleased that the Group is expected to deliver such encouraging results.

Current Trading

Following the severe downturn in the UK and US residential housing markets in the second half of 2008, the Group's Building Products division continued to experience difficult trading conditions in the first half of 2009.  Management took early action to control overheads and costs, putting in place a number of measures including short-term working, headcount reduction, site rationalisation and tight control over cash and working capital.  

During the second half, the businesses stabilised and have benefitted from higher levels of activity which have been sustained through to the year-end. A number of businesses have now returned to full time working in order to meet increased demand; however, the Group continues to focus on controlling its cost base. Should end market conditions deteriorate again, the Group has already demonstrated its ability to react swiftly when required.  

Gall Thomson Environmental continues to maintain its strong market position and has performed in line with management's expectations, producing excellent results.

Financial Position

In 2009 the Group generated strong free cash and was able to repay just under £23 million of debt.  At 31 December 2009 the Group's net debt was approximately £111 million (2008: £145.3 million) with cash balances of approximately £25 million (2008: £32.4 million). Of the reduction in net debt, just under £15 million relates to movements in exchange rates.

In December 2009US$66 million of dollar debt was redenominated into sterling, thereby aligning the Group's debt profile more closely with its earnings flows.

The Board remains confident that the Group will continue to operate within its banking covenants.

Outlook

The Group remains cautious as we enter 2010, as trading conditions are not expected to improve rapidly and, despite encouraging recent trading, our end markets remain fragile.  Lupus weathered a difficult and challenging 2009 trading climate and is now focussed on reinforcing its strong position in the Group's markets.

Enquiries: 

Lupus Capital plc

Denis Mulhall (Interim CEO)

Paul Felton-Smith (CFO)

Tel: +44 (0)20 7976 8000

Collins Stewart Europe Limited 

Mark Dickenson / Tom Hulme

Tel: +44 (0)20 7523 8350

College Hill

Mark Garraway / Gareth David

Tel: +44 (0)20 7457 2020

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLALLIFFII
Date   Source Headline
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNotice of Results
28th Dec 20223:53 pmRNSHolding(s) in Company
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings
5th Oct 20225:01 pmRNSHolding(s) in Company
5th Oct 20225:00 pmRNSHolding(s) in Company
5th Oct 20224:04 pmRNSHolding(s) in Company
19th Aug 20223:33 pmRNSHolding(s) in Company
1st Aug 20223:34 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSHalf-year Report
17th Jun 20224:23 pmRNSHolding(s) in Company
6th Jun 20228:08 amRNSDirector/PDMR Shareholding
24th May 20229:57 amRNSDirector/PDMR Shareholding
19th May 20224:41 pmRNSDirector/PDMR Shareholding
19th May 20224:40 pmRNSResult of AGM
19th May 20227:00 amRNSAGM Trading Update
26th Apr 20225:14 pmRNSHolding(s) in Company
25th Apr 20223:36 pmRNSHolding(s) in Company
20th Apr 20223:59 pmRNSDirector/PDMR Shareholding
11th Apr 202211:30 amRNSDirector/PDMR Shareholding
1st Apr 20224:00 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNotice of AGM
31st Mar 20229:56 amRNSHolding(s) in Company
31st Mar 20229:51 amRNSHolding(s) in Company
29th Mar 20223:07 pmRNSHolding(s) in Company
29th Mar 202212:00 pmRNSEBT Purchase
29th Mar 202210:54 amRNSHolding(s) in Company
15th Mar 20227:00 amRNSRefinancing of US Private Placement Notes
10th Mar 20223:12 pmRNSDirector/PDMR Shareholding
10th Mar 20222:43 pmRNSHolding(s) in Company
8th Mar 202212:09 pmRNSHolding(s) in Company
3rd Mar 20223:21 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
22nd Feb 20224:10 pmRNSNotice of Results
25th Jan 202210:05 amRNSDirector Declaration
16th Dec 20217:00 amRNSNew Non-Executive Director
25th Nov 202112:57 pmRNSTotal Voting Rights
17th Nov 20217:00 amRNSTrading Update
28th Oct 20219:43 amRNSHolding(s) in Company
14th Sep 20217:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.